Esteve to buy German pharma firm Riemser from Ardian

Riemser specialises in oncology, neurology, and infectiology and had since 2012 been part of Ardian's portfolio. Ardian in 2018 unsuccessfully tried to sell the company and relaunched an auction last year.

New Delhi: Spanish pharmaceuticals company Esteve has agreed to buy German peer Riemser from Ardian, the French buyout group said in a statement on Wednesday.

Also Read: FTC seeks to block Illumina from buying PacBio

Financial details of the transaction, which is expected to close in the first quarter, were not disclosed.

Riemser specialises in oncology, neurology, and infectiology and had since 2012 been part of Ardian's portfolio. Ardian in 2018 unsuccessfully tried to sell the company and relaunched an auction last year.

Also Read: Astellas Pharma to buy Audentes Therapeutics for USD 2.7 billion